← Biopharmaceutics and Pharmacokinetics Practicals

Comparison of Dissolution of Two Marketed Products of the Same Drug

1. Aim

To study year 4 biopharmaceutics 2 using supervised records and report the supported outcome. Actual case, sample, and result must be entered in the student record.

2. Requirements

Approved de-identified dataset or teaching case, current method, source identifiers, calibration and control records where relevant, graphing or calculation tool, supervisor, and privacy or safety procedure. Record the assigned sample and use approved software. Drug identity, dose, and acceptance criteria are to be recorded from the assigned current monograph or approved college method in the student record.

3. Theory

Two products with the same active drug can have different dissolution profiles. A fair comparison requires matched apparatus, medium, sampling schedule, dose basis, and validated assay. Profile similarity is assessed under the applicable guidance; one time point cannot prove equivalence.

4. Procedure

Confirm the syllabus entry, approved source, ethics or privacy requirements, and method.
Record actual labels, units, time points, controls, and missing information without guessing.
Work through the supervised case or dataset: Record product identities and approved method. Compare replicate percent-dissolved profiles at matched time points and assess whether the prescribed similarity method applies.
Separate raw observations from calculations and check method suitability.
Use verified formulae and local software only if the full dataset and method support them.
State the supported result, limitations, and every missing item as Record here.

5. Observation and calculation

Student record field	Entry
Case or product	Record here
Method	Record here
Observation	Record here
Inference	Record here
Supervisor check	Record here
Outcome	Record here

Assumed values or observations for practice only: Assumed product A gives 70% and assumed product B 74% at one assumed time. The assumed 4-point difference is not a bioequivalence decision. All invented inputs and outputs are assumed, not a patient result or laboratory instruction.

6. Output or final result

Provide a labelled two-product dissolution profiles and supervisor-reviewed conclusion. Record the supervised outcome here.

Teaching-lab safety: Clinical cases must be de-identified and supervised. Human or animal bioavailability work requires prior ethical authorization. No assumed example authorizes dosing or sampling. Software-dependent fitting belongs in the actual lab with its approved program.

This page is a supervised-activity guide; it does not report a completed case.

7. Sources

← Improvement of Dissolution of Slightly Soluble DrugsInfluence of Polymorphism on Solubility and Dissolution →

Back to Biopharmaceutics and Pharmacokinetics Practicals · All Pharm D Practicals · Pharm D

Theory notes: Pharm D Year 4, 4.5 Biopharmaceutics and Pharmacokinetics